VERICEL CORPORATION Employee Count
The employee counts VERICEL CORPORATION states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 398; Filing 2026-02-26; Lease expense per employee $1,005.03.
- 2024-12-31: Employees (as filed) 357; Filing 2025-02-27; Lease expense per employee $1,120.45.
- 2023-12-31: Employees (as filed) 314; Filing 2024-02-29; Lease expense per employee $636.94.
- 2022-12-31: Employees (as filed) 305; Filing 2023-02-23; Lease expense per employee $655.74.
- Available history
- 2015-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 398 full-time | 2026-02-26 | $1,005.03 short-term + finance interest |
| 2024-12-31 | 357 full-time | 2025-02-27 | $1,120.45 short-term + finance interest |
| 2023-12-31 | 314 full-time | 2024-02-29 | $636.94 short-term + finance interest |
| 2022-12-31 | 305 full-time | 2023-02-23 | $655.74 short-term + finance interest |
| 2021-12-31 | 281 full-time | 2022-02-24 | $16,448.40 short-term + finance amortization + finance interest |
| 2020-12-31 | 273 full-time | 2021-02-24 | $17,014.65 short-term + finance amortization + finance interest |
| 2019-12-31 | 241 full-time | 2020-02-25 | $12,394.19 short-term + finance amortization + finance interest |
| 2018-12-31 | 216 full-time | 2019-02-26 | $462.96 finance amortization + finance interest |
| 2017-12-31 | 205 full-time | 2018-03-05 | $0.00 finance amortization |
| 2016-12-31 | 202 full-time | 2017-03-13 | $23,762.38 rent expense, net |
| 2015-12-31 | 190 full-time | 2016-03-14 | $25,789.47 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |